Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Abraxane in Advanced Breast Cancer
NCT00934895Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Jul 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Rutgers University. Started Jul 2009; status: terminated.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00934895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934895.